Redeye provides an update following Corline’s Q4 2025 report. Quarterly sales came in below our expectations, and we are still awaiting a clearer ramp-up linked to Kardium’s launch of the Globe system. Following the report, we have made some downward adjustments to our estimates, primarily FX-related but also reflecting a more cautious approach to near-term projections, resulting in an updated fair value range.
LÄS MER